ABSTRACT Dopamine (DA) neuron subtypes modulate specific physiological functions and are involved in distinct neurological disorders. Embryonic stem cell (ESC) derived DA neurons have the potential to aid in the study of disease mechanisms, drug discovery, and possibly cell replacement therapies.
INTRODUCTION
Dopamine (DA) neurons in the midbrain are a diverse population and consist of subtypes with distinct anatomical and molecular identities [1] . When defined by anatomical region, the major groups are the substantia nigra (SN) or the A9 group and the ventral tegmental area (VTA) or the A10 group [2] . SN DA neurons, which innervate the dorsal striatum, are essential for initiating movement and controlling postural reflexes [1, [3] [4] [5] . VTA DA neurons, which project to the ventral striatum, limbic, and cortical areas, are involved in cognition, reward, and emotional behavior [2, 6, 7] . Degeneration of SN DA neurons leads to the loss of motor function in Parkinson's disease [8] , while abnormal activity of VTA DA neurons may underlie schizophrenia, addiction, and attention deficit hyperactivity disorder [1, 3, 7, 9, 10] .
The heterogeneous molecular identity of DA neurons adds further complexity to their subtype characterization. Calbindin (CALB), a calcium-binding protein, is enriched in the majority of VTA DA neurons and in a subset of SN DA neurons [11] [12] [13] [14] [15] [16] . A recent study suggested that CALB buffers DA vesicle release in healthy VTA neurons [17] . The expression of CALB may protect DA neurons from calcium cytotoxicity-induced degeneration as VTA DA neurons are less affected than SN DA neurons in Parkinson's disease [12, 18, 19] . Calretinin (CALR), another calcium-binding protein, is expressed in DA neurons scattered in the VTA and SN [14] [15] [16] . The physiological function of CALR is not well understood, but it has been suggested that CALR may have similar neuroprotective properties to CALB [20, 21] . A third protein, G-protein-regulated inward-rectifier potassium channel 2 (GIRK2), is expressed in nearly all SN DA neurons, which undergo the greatest degree of degeneration in Parkinson's disease [11, 22, 23] . The expression of CALB, CALR, and GIRK2 is not mutually exclusive and gives rise to diverse subtypes of DA neurons [14] [15] [16] 24, 25] .
Because of their clinical relevance, the generation of DA neurons in vitro offers opportunities to study disease mechanism, progression and therapeutics, and holds potential for cell replacement therapy [26] [27] [28] [29] . A well established method of deriving DA neurons from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) in vitro is a 5-stage differentiation method first described by Lee et al. [30] . Each stage utilizes a defined culture substrate and media and cells become lineage-restricted as they pass through each stage. Differentiated neurons are observed at the end of the protocol with DA neurons accounting for a small percentage of all neurons. The DA neuron population generated using this 5-stage method is not homogeneous [31] [32] [33] and the subtype profile has not been quantitatively analyzed.
The efficiency of DA neuron production with the 5-stage method may be enhanced by exposing neural progenitors at the fourth stage to exogenous sonic hedgehog (SHH) and fibroblast growth factor 8 (FGF8). SHH and FGF8 are two morphogens required for inducing DA neuron fate in the midbrain during embryonic development in vivo [34] . At embryonic day 8.5 (E8.5) SHH is expressed along the ventral midline and FGF8 in the isthmus at the mid/hindbrain boundary [35] .
The intersection of these two morphogens is where DA neuron progenitors appear during embryogenesis [34] . A SHH gradient has been shown to be involved with motor neuron subtype specification in the spinal cord [36] , but it is unknown whether soluble morphogens play a role in the subtype specification of DA neurons in vitro.
In this study, we established a sampling approach to quantify DA neuron subtypes in heterogeneous cultures. We evaluated the generation of DA neuron subtypes from a baseline 5-stage culture, in which no exogenous SHH and FGF8 were added. Among the DA neurons that were generated we detected the expression of CALB and CALR, but not GIRK2. We then conducted quantitative analysis of the CALB+ and CALR+ subtypes of DA neurons. We further investigated whether the distribution of CALB+ and CALR+ subtypes could be manipulated by the addition of SHH and FGF8 at different stages. We discuss these findings in the context of subtype specification of DA neurons in vitro. supplemented with 1400 U/mL ESGRO leukemia inhibitory factor (LIF, Millipore, ESG1107). ESCs were cultured for 1-2 days before colonies contacted each other and were dissociated using 0.05% trypsin (Invitrogen, 25300). The ESCs were passaged onto a new iMEF monolayer, cryopreserved in ES media with an additional 10% FBS and 10% DMSO (Sigma, D2650), or used for DA neuron differentiation (see below). Passage number of D3 ESCs was not provided by ATCC, and therefore we designated passage 1 (P1) as the purchased vial.
MATERIALS AND METHODS

Mouse embryonic stem cell culture
DA neuron differentiation
We used a 5-stage protocol, with a baseline culture that was slightly modified from the 5-stage method first described by Lee et al. in 2000 [30] and commercialized by R&D Systems (Human/ Mouse DA Neuron Differentiation Kit, R&D Systems, SC001b). The five stages of baseline culture conditions were as follows (illustrated in Figure 1 and shown in Supplementary Figure 1 Experimental conditions: (a) SHH (500 ng/mL) and FGF8 (100 ng/mL) were added during Stage IV (S500F100IV). The paired control (S0F0IV) was conducted in parallel. (b) SHH (500 ng/mL) and FGF8 (100 ng/mL) were added during Stage III (S500F100III). The paired control (S0F0III) was conducted in parallel. (c) Anti-SHH (10 µg/mL) and anti-FGFR3 (10 µg/mL) antibodies were added at the start of Stage III until the end of the experiment (αSαFr). The paired control (S0F0 α ) was conducted in parallel. Differentiated cells at the end of Stage V were immunolabeled for TH (DA neurons), NeuN (neurons), and subtype markers CALB, CALR, and GIRK2. NPs at the end of Stage III were immunolabeled for Nestin (NP) and LMX1a (transcription factor associated with DA neuron progenitors). Undifferentiated ESCs and cells at the end of Stage IV were analyzed for the mRNA expression of SHH and FGF8 signaling components, namely Shh, Gli1, Fgf8, Fgfr3, Wnt1, Tcf4, and Nfat.
In the first experiment, passage 3 (P3) of D3 ESCs and P21 of R1 ESCs were used ( Figure   1a, S500F100IV,) . SHH (500 ng/mL, R&D, 461-SH-025/CF) and FGF8 (100 ng/mL, R&D, 423-F8-025/CF) were added to N2aa media and refreshed upon media exchange during NP expansion (Stage IV). In the second experiment, P5 of D3 ESCs was used, and SHH and FGF8 were added to the ITSFn media during NP selection (Stage III) and refreshed upon media exchange (Figure 1b,   S500F100III ). In the third experiment, P5 of D3 ESCs was used (Figure 1c, αSαFr) . Anti-SHH (10 µg/mL, R&D, MAB4641) and anti-FGFR3 (10 µg/mL, R&D, MAB710) antibodies were added at the beginning of Stage III to the end of Stage V. Antibodies were refreshed upon media change.
A common problem with ESC culture is the variation among sub-clones [37] . To remove confounding variables, all experiments described in this study were conducted in parallel with a paired control group (S0F0IV, S0F0III, and S0F0 α ) using the baseline culture protocol. The 
Immunocytochemistry
Immunocytochemistry was carried out using standard protocols [14] . Primary antibodies were diluted in working solution [phosphate buffered saline (PBS), 10% normal donkey serum and 0.2% 
Sampling size selection by Monte Carlo simulation
The Monte Carlo error model was used to estimate error and help determine our sub-sampling method. The model was based on large coverage sampling of DA neuron-containing cultures by imaging eighty non-overlapping fields of view (operationally, we define multiple fields as FOVs) with a 20X objective; this was applied to two separate culture samples. The number of TH+ neurons in each FOV was manually counted as described above. A Matlab simulation was developed to randomly select subsets of N numbers of FOVs and calculate the average number of TH+ neurons based on the actual counts from the subset of FOVs. The simulation was executed 1000 times for all subset sizes. The standard errors were calculated from the standard deviations of the 1000 averages for each sampling size.
Quantitative Real Time PCR (qRT-PCR)
Three experimental groups including undifferentiated ESCs and NPs derived from S0F0IV and S500F100IV conditions were harvested for RNA extraction. For each of the groups, multiple wells (n > 2) were collected to generate biological replicates. RNA was extracted using Trizol (Invitrogen, 15596-026) and purified using a RNeasy Mini Kit (Qiagen, 74104) according to manufacturers' instructions. RNA was quantified using Nanodrop ND-1000. A 0.5 µg RNA template was used to synthesize cDNA using iScript cDNA Synthesis Kit (BioRad, 170-8890) according to manufacturer's instruction. The cDNA from each biological replicate was run in three separate qRT-PCR reactions (in triplicate) for each primer set. Quantitative RT-PCR (qRT-PCR) was performed with SYBR Green (Applied Biosystems, 4367650) using ABI 7900 Fast Sequence Detection Instrument. Expression of Shh, Gli1, Fgf8, Fgfr3, Wnt1, Tcf4, and Nfat were analyzed and normalized to 18S. Results are reported as mean cycle threshold, standard deviation, and significance determined by two-tailed p value. Cycle times were graphed using a log(2) scale to match cycle times. See S1 Table for primer sequences.
Statistical Method
Thirty FOVs were analyzed for each marker combination in each culture sample. Statistical analyses of TH+/mm 2 , NeuN+/mm 2 , TH+/NeuN+, TH+CALB+/TH+, and TH+CALR+/TH+ neurons were performed in SAS software and Generalized Estimating Equations were used to test all hypotheses. FOVs within each coverslip were modeled to have correlated residual error. For analyses comparing the percent of one type of cell within a larger pool of cells (e.g. TH+CALB+/ TH+, TH+CALR+/TH+, and TH+/NeuN+) a binomial distribution was used, which describes the probability distribution of the number of successes (e.g. TH+CALB+) in a sequence of trials (e.g. TH+). Binomial distribution appropriately constrains values between 0-100%, models the way the variability of percentages skewed above and below 50%, and scales the variability by the size of the denominator. For analyses comparing the number of TH+ neurons per area (e.g. TH+/mm 2 ) a Poisson distribution was used, which describes the number of events (e.g. TH+) one would observe in a fixed event rate (events per mm 2 ). Unlike binomial distribution, Poisson distribution appropriately constrains values only to ≥ 0.
Once the appropriate distribution models were fit for the dependent variable (TH+/mm 2 , TH+/NeuN+, TH+CALB+/TH+, and TH+CALR+/TH+), individual orthogonal linear estimates were constructed within the models to test specified hypotheses. Families were defined within a dependent variable as comparisons between experimental conditions and their paired controls.
Familywise alpha was maintained at 0.05 using the Holm test to create adjusted p-values, and statistical significance was defined as adjusted p < 0.05. Comparisons among controls were also conducted to assess the variability among ESC lines and passages. Finally, classical sandwich estimation was used to adjust the final model parameters based on how closely the parameters fit the distribution of the data. Means and 95% confidence intervals (CI) are reported.
RESULTS
Quantification using Monte Carlo simulation
We generated DA neurons from ESCs using a modified version of the 5-stage method (See Methods, Figure 1) . Immunolabeling for TH revealed that the in vitro distribution of TH+ (DA) neurons generated from ESCs was highly heterogeneous (Figure 2a and Supplemental Figure 2 ). To quantitatively evaluate our cultures in an unbiased manner we selected a sampling size to ensure accuracy while taking into account sampling error and efficiency. As illustrated in between sampled FOVs. We made the assumption that 80 FOVs yielded sufficient coverage to represent the entire culture. We manually counted the number of TH+ neurons in each FOV and calculated the average from the 80 FOV counts (Average TH+80) (Figure 2c) . We did the same for TH+CALB+ neurons from the 80 FOV counts (Average TH+CALB+80) (Figure 2d) . We then used a Monte Carlo error model to assess the error associated with randomly sampling smaller subsets from the 80 FOVs (Figure 2e) . Specifically, we defined sample size N, where 0 < N < 80. A set of N numbers of FOVs was randomly selected from the 80 FOVs, and the average TH+ counts from this subset was calculated (Average TH+N). This process was executed 1000 times for each sample size N. The 1000 Averages TH+N deviated from Average TH+80 to varying extents (Figure 2f) . The standard deviation of the 1000 averages was calculated, which by definition is the standard error of the sample (Figure 2h , green line). As expected, it was found that with larger sampling size there was a smaller resulting error. For example, the errors were ±27.43% for 10 FOV, ±17.04% for 20 FOV, ±13.05% for 30 FOV, and ±9.75% for 40 FOV. Taking into consideration the error and the efficiency of performing the counts, we concluded that 30 FOVs per sample provided sufficient representation of the cultures and an acceptable amount of error. We repeated this process for TH+CALB+ neurons (Figures 2d,g,h) and reached a similar conclusion. Subsequently, all cultures described in this study were analyzed by imaging 30 randomly selected FOVs.
5-stage method generated more CALB+ than CALR+ subtype in D3-derived DA neurons
We assessed the generation of DA neuron subtypes by double immunolabeling for TH and CALB, TH and CALR, or TH and GIRK2 following a 5-stage culture paradigm in the absence of exogenous SHH and FGF8. We observed qualitatively more TH+CALB+ DA neurons versus TH+CALR+ DA neurons which was verified by quantitation (Table 1 and Figure 3a,c) . We also observed many TH-CALB+ neurons and a smaller number of TH-CALR+ neurons, presumably interneurons, which were not quantified in our study. We did not detect TH+GIRK2+ neurons at the end of the 10-day differentiation period. GIRK2+ expression was observed when we extended differentiation to 25 days (Supplemental Figure 3) . For the purpose of this study, we restricted our quantitative analysis to the standard differentiation duration typically cited in the literature [30] . The percentage of TH+ DA neuron subtypes generated with the S0F0IV baseline culture condition was 26.24% for the CALB+ subtype, which was significantly higher than 13.14% for the TH+CALR+ subtype (p < 0.0001) (Table 1 and Figure 3e ).
The role of exogenous SHH and FGF8 during Stage IV on DA neuron subtype generation from D3 ESCs
The addition of SHH and FGF8 during NP expansion (Stage IV), but not prior or after, has been reported to enhance DA neuron production [30] . To study if exogenous SHH and FGF8 shape DA neuron subtype generation, we supplemented culture media with exogenous SHH (500 ng/mL) and FGF8 (100 ng/mL) during Stage IV (500F100IV,) in parallel to the S0F0IV baseline culture (Figure 3) . The S500F100IV conditions yielded 27.25% CALB+ DA neurons (Figure 3a,b,e) , which was significantly higher than 10.95% of the CALR+ DA neuron subtype (Figure 3c,d,e) (p < 0.0001) ( Table 1) . These findings were similar between the S0F0IV and S500F100IV groups ( Table   1 ). The comparison of CALB+ subtype across the S0F0IV and S500F100IV groups revealed no difference (p = 1.000) while the comparison of CALR+ subtype across the S0F0IV and S500F100IV groups revealed a 2.19% difference (p = 0.010). To validate the effect of exogenous morphogens on total DA neuron production we asked whether exogenous SHH and FGF8 in the S500F100IV condition altered the production of TH+ neurons from D3 ESCs compared to the S0F0IV condition. The total TH+ neuron production in S0F0IV
(123.12 TH+/mm2) was not significantly different from S500F100IV (98.34 TH+/mm2, p = 0.406) ( Table 2 and Figure 4) . The total neuron production in S0F0IV (2,110 NeuN+/mm2) was not significantly different from S500F100IV (1,867 NeuN+/mm2, p = 0.877). The percent of TH+ neurons within the total NeuN+ neuronal population in S0F0IV (6.18%) was also not significantly different from S500F100IV (6.49%, p = 1.000). This data shows that exogenous SHH and FGF8 did not significantly affect total neuron or DA neuron production derived from D3 ESCs. Table 2 . with qRT-PCR analysis of DA neuron progenitors isolated in vivo [42] .
Comparative analysis with R1 ESCs: DA neuron production and subtype generation
To investigate whether the results we observed were unique to the D3 ESCs, we performed the same experiments using R1 mouse ESCs. R1 ESCs were cultured using the same baseline control and experimental conditions (S0F0IV vs. S500F100IV). TH+ neuron production in S0F0IV (186.65 TH+/mm 2 ) was not significantly different from S500F100IV (202.12 TH+/mm 2 ) (p = 0.508, Table 2 and Figure 6 ). These results show that similar to D3 ESCs, the production of TH+ neurons from R1 
Exogenous SHH and FGF8 during NP selection (Stage III) did not alter the proportion of DA neuron subtypes derived from D3 ESCs
Previous studies suggested that SHH and FGF8 did not affect DA neuron production when added before Stage IV [30] . Immunolabeling of ESC-derived NPs at Stage III revealed that LMX1a, a transcription factor and determinant of DA neurons, was distributed amongst Nestin+ NPs (Supplemental Figure 4) . We therefore tested whether exposure to exogenous SHH and FGF8 at this earlier stage (Stage III) impacted DA neuron subtype generation. As illustrated in Figure 7a -d, SHH (500 ng/ml) and FGF8 (100 ng/mL) or no morphogens were added to the culture only during
Stage III (denoted as S500F100III) (Figure 7b,d,e) . Paired controls were cultured using baseline culture conditions (denoted as S0F0III) (Figure 7a,c,e) . CALB+ (12.31%) DA neurons were more abundant than the CALR+ subtype (8.53%, p < 0.001) in S0F0III (Figure 7e , detailed in Table 1 ).
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Figure 7. SHH and FGF8 at Stage III did not substantially govern CALB+ DA neuron subtype generation. D3 ESCs were cultured in parallel in the S0F0III baseline condition and in the S500F100III condition, in which exogenous SHH (500 ng/ml) and FGF8 (100 ng/ml) were added during NP selection (Stage III) The CALB+ subtype (11.01%) was also significantly higher than CALR+ subtype (8.81%, p = 0.0142) in S500F100III (Figure 7e) . Comparison of CALB+ subtypes of DA neurons across culture conditions revealed a 1.30% difference (p = 0.025). There was no difference in the CALR+ subtype between S0F0III and S500F100III (p = 1.000). In addition, there was no increase in the production of neurons or TH+ neurons with the presence of SHH and FGF8 during NP selection. We did not observe differences in DA neuron production, neuron production, or the percentage of DA neurons to total neurons between S0F0III and S500F100III (Supplemental Figure 5 and Table 2 ).
Treatment with SHH-and FGFR3-neutralizing antibodies did not alter CALB+ or CALR+ subtype generation
Because Shh and Fgf8 expression were detected at Stage IV regardless of exogenous SHH and FGF8 ( Figure 5 ), we used neutralizing antibodies to block endogenous SHH and FGFR3 ( Figure 8) ;
FGFR3 is the receptor for FGF8 [34] . Cells were incubated with anti-SHH (10 µg/mL) and anti- FGFR3 (10 µg/mL) antibodies from the beginning of Stage III through the end of Stage V (Figure 1c; denoted as αSαFr). Under these conditions, the cultures did not receive exogenous SHH and FGF8
( Figure 8 and Table 1 ). The paired control group received neither exogenous SHH and FGF8, nor anti-SHH and anti-FGFR3, denoted as S0F0 α . In S0F0 α , the CALB+ subtype (12.49%) was significantly higher than the CALR+ subtype (9.04%, p < 0.0001), in agreement with the previous control groups. In αSαFr, the CALB+ subtype (12.43%) was higher than the CALR+ subtype (8.21%, p = 0.0084). There was no difference in the CALB+ (p = 1.000) or CALR+ subtype (p = 0.467) in S0F0 α and αSαFr conditions. We did not observe differences in DA neuron production or the percentage of DA neurons in S0F0 α and αSαFr conditions (Supplemental Figure 5 and Table 2 ).
DISCUSSION
Midbrain DA neurons in vivo consist of several subtypes with unique molecular identities and are involved in distinct neurological disorders [3, 7, 12 ]. An understanding of how specific subtypes of DA neurons are generated in vitro is important for developing appropriate research tools for studying disease mechanisms, investigating potential therapeutics, and adopting stem cells for clinical applications [8] . In this study, we differentiated DA neurons from ESCs using a 5 The role of SHH and FGF8 in ESC-derived DA neurons SHH and FGF8 are morphogens that function in embryonic patterning and play a role in the induction of DA neurons in the embryonic brain [34, [39] [40] [41] . These two morphogens have been suggested to enhance DA neuron production in vitro [30, 31, 46] . However, we did not observe an increase in the production of DA neurons in the presence of exogenous SHH and FGF8 from two independent ESC lines. There are several potential explanations for these findings including the following: 1) variations in ESCs and experimental procedures, 2) saturating levels of endogenous SHH and FGF8, and 3) context-dependent functions of SHH and FGF8.
The production of DA neurons from ESCs can be influenced by variations in cell line and experimental procedures. With regard to cell lines, we utilized both D3 and R1 ESCs for our experiments because these commercially available lines have been used previously in DA neuron differentiation experiments with the 5-stage protocol [30, 31, 47] . It is noteworthy that the descriptions of DA neuron production in the literature have indicated a range in the yield of DA neurons derived from ESCs treated with SHH and FGF8 (7% → 33% of total neurons reported by Lee et al. [30] ; 3 →11% reported by Chung et al. [31] ; 6% in this study). One experimental difference between previously published studies and ours is that we counted TH+ neurons versus NeuN+ neurons, which is restricted to neuronal nuclei and more amenable to cell counting than TUJ-1, which is expressed in neuronal soma and processes. However, it is also possible that our ESCs were at a passage that did not maximally respond to exogenous SHH and FGF8. Studies have reported variations in proliferation, differentiation, and genetic abnormalities with ESC subclones and passages [37, 48] . Because passage numbers of ESCs are often unknown or not reported in literature it is difficult to directly compare across studies, which necessitates the need to run untreated control groups. To eliminate reagent variability as a potential influence on cell responses, we compared reagents from a commercial DA neuron differentiation kit (R&D, sc001b) to reagents individually purchased (listed in Methods); we observed no differences in DA neuron production.
With regard to endogenous morphogen levels, our qRT-PCR analysis showed that mRNA levels of SHH and FGF8 signaling components were upregulated in cells at the NP expansion stage compared to undifferentiated ESCs indicating that some cells in vitro acquire robust expression of endogenous Shh and Fgf8. Along with the upregulation of Wnt1, these results are consistent with previous in vitro studies and are in alignment with in vivo development [30, 42] .
The addition of exogenous SHH and FGF8 did not increase the expression levels of endogenous pathway components, but interestingly there was a decrease in the expression of Fgfr3 in the presence of exogenous FGF8, consistent with a negative feedback loop of FGF8 signaling [49] . The dynamic change in intrinsic gene expression from ESCs to NPs and the lack of a robust functional response to exogenous SHH and FGF8 suggest that NPs produce sufficient and/or saturated levels endogenously and may be a self-sufficient system for limited DA neuron production. We directly tested the role of endogenous SHH and FGF8 signaling with neutralizing antibodies [34] and saw no decrease in the number of TH+ neurons. These results suggest that a low level of endogenous morphogen persisted in the presence of the antibodies or that a short pulse of morphogen activity occurred prior to blocking antibody disruption, which would be consistent with the dynamic temporal requirement for morphogen induction of DA neurons in vivo [14, 34, 41] .
We confirmed the pluripotency of D3 ESCs with OCT4 expression, which was further supported by the ability to generate DA neurons, CALB+ and CALR+ neurons, and a substantial number of additional neurons. We also observed the acquisition of LMX1a expression in DA progenitors at an appropriate stage. However, our findings and previous studies collectively indicate that the majority (67 -94%) of NPs do not differentiate into DA neurons in response to exogenous SHH or FGF8 [30, 31] . SHH and FGF8 have been observed to fail to transdifferentiate striatal neurons to express TH in vitro [50] . While SHH and FGF8 are potent morphogens for DA neuron induction in vivo, it is important to note that they act on specific precursor cells suggesting context-dependent functions of these morphogens. SHH is involved in the induction of not only DA neurons, but also serotoninergic neurons, motor neurons, and GABAergic interneurons. This shows that the same factor can have different effects depending on the recipient cells [36, [51] [52] [53] .
Further, it is only within a critical window in vivo that SHH and FGF8 can induce ectopic DA neuron production [34] . It is interesting to note that when ESC-derived NPs overexpress key transcription factors such as Nurr1 and Lmx1a, these NPs produced 60-80% DA neurons when exposed to SHH and FGF8 [31, 32, 47] . Taken together, these studies suggest that many of the microenvironmental cues that can influence cell fate may be missing in vitro. Alternatively, there may be an unidentified mechanism(s) that ensures only a limited number of progenitors are poised to acquire a DA neuron identity. Other mechanisms are likely to be involved with subtype specification, such as other soluble morphogens, progenitors niche, cell-cell communication, migration and refinement of progenitors, and intrinsic gene expression [54] . It is likely that additional intrinsic and extrinsic factors and mechanisms are required to work synergistically with exogenous SHH and FGF8 to enhance DA neuron production.
DA neuron subtypes derived from mouse ESCs
After ten days of differentiation, a small percentage of DA neurons in our culture expressed CALB (11 -27%) or CALR (2 -13 %). Remarkably, our culture conditions recapitulated the relative distribution of these subtypes of DA neurons in the mouse brain, which also has a higher percentage of CALB+ versus CALR+ DA neurons in the midbrain [15, 16, 55] . The differences in percentages between DA neuron subtypes produced in vitro and established in vivo may reflect differences in the time, context, or embryonic niche where DA progenitors are located compared to culture conditions. CALB and CALR expression in DA neurons are not mutually exclusive in vivo [16] . Although we did not perform triple-immunolabeling of TH, CALB, and CALR due to antibody compatibility complications, it will be interesting in the future to quantify the co-expression of CALB and CALR in DA neurons. Because cognitive function and reward-associated behaviors involve DA neurons located in the VTA, which is high in CALB+ and CALR+ DA neuron subtypes, our findings regarding the in vitro production of these subtypes is potentially applicable to aid in the study of complex disorders such as schizophrenia, addiction, reward, and arousal. The GIRK2+ subtype of DA neurons in the SN is vulnerable to degeneration in Parkinson's disease [12] and transplanting an enriched population of SN DA neurons has led to greater motor function recovery in a rat Parkinson's disease model [4, 11] . In this study, we did not detect GIRK2 expression at the end of fairly standard differentiation duration (10-15 days) in the 5-stage paradigm. However, previous studies have detected GIRK2 expression in DA neurons derived from a similar paradigm after being engrafted in animal models with DA neuron lesions [32, 56, 57] . Thus, DA neurons derived from ESCs have the ability to become the GIRK2+ subtype of DA neurons. The absence of GIRK2 expression may be explained by the temporal dependency, intrinsic mechanisms, or microenvironment [39] . The assertion of temporal dependency is supported by our observation that a small number of GIRK2 expressing DA neurons was observed after 25 days in vitro.
Finally, we hypothesized that the generation of DA neuron subtypes is influenced by exogenous SHH and FGF8. The rationale for testing our hypothesis is that precursor cells in the developing midbrain are exposed to different concentrations of SHH and FGF8 secreted by the ventral midline and isthmus, respectively [34] . Subtype specification through a SHH gradient has been demonstrated in spinal cord motor neurons [36] . In addition, SHH and FGF8 gradients control cell fate specification in limb bud development [58, 59] . Surprisingly, the addition of SHH and FGF8 at the NP expansion stage did not alter the production of the CALB+ subtype of DA neuron and resulted in a minor decrease of CALR+ DA neurons. Even though the decrease was statistically significant, the change was very small and in our opinion unlikely to be an efficient method to manipulate DA neuron subtype generation in vitro. Similarly, neutralizing antibodies did not alter the number of CALB+ or CALR+ DA neuron subtypes. These findings suggest that subtype generation in vitro is not governed by exogenous SHH and FGF8, but may be controlled by intrinsic mechanisms such as transcription factors. We did note a significant difference in the percentages of both CALB+ and CALR+ DA neuron subtypes derived from earlier versus later ESC passage, although the pattern of more CALB+ than CALR+ DA neurons remained. These results suggest that DA subtype specification may be sensitive to intrinsic factors and starting ESC passage, which agrees with literature that reported variability in the yield of differentiated cells among subclones of the same ESCs [37] .
CONCLUSION
We established a rigorous analytical approach to sampling and quantify DA neuron subtypes generated from ESCs using a 5-stage method. 
